IP Verse

Nerve Growth Factor Composition And Powder Injection

PatentPatent Analysis

EP3287139

BEIJING STAIDSON MEDICAL TECHNOLOGY
Application Number
EP16782600A
Filing Date
Apr 18, 2016
Status
Revoked
May 10, 2024
Grant Date
Aug 11, 2021
External Links
Slate, Register, Google Patents
Similar Patents facing opposition
EP3287140B1

Bibliography

The patent EP3287139B1 was granted to Beijing Staidson Medical Technology on Aug 11, 2021 following the initial filing on Apr 18, 2016 under the application number EP16782600A . The current legal status of the patent is Revoked.

AI Generated Summary New

Patent Family

Patent Family

Patent Oppositions filed by Competitors

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

DOMPE FARMACEUTICIMay 11, 2022ADMISSIBLE

Dossier Documents of the Patent

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents